Akebia Therapeutics AKBA
NASDAQ AKBA
$0.92 +0.03 (+3.37%)
At close: Sep 30, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Other financing activities (2021 - 2025)

Updated

Akebia Therapeutics (AKBA) posted Other financing activities of $63,000 for FY2025, down 95.0% from $1.27 million in FY2024.

Analysis

Akebia Therapeutics (AKBA) Other financing activities (2021 - 2025) Analysis & Trends

Since FY2021, Akebia Therapeutics has reported Other financing activities for 4 years.

  • Annual Other financing activities shows a four-year compound annual growth rate of -80.6% (FY2021 to FY2025).
  • Business Quant data shows AKBA's Other financing activities at $1.27 million in FY2024, $40 million in FY2022 (-10.7%) and $44.78 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Akebia Therapeutics 250.00 Mn -419.48 Mn 38.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 63,000.00
Sep 30, 2024 522,000.00
Mar 31, 2024 750,000.00
Mar 31, 2022 40.00 Mn
Mar 31, 2021 44.78 Mn
API Access

Akebia Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AKBA&period=max&api_key=YOUR_API_KEY